Oncotarget is a medical journal that has a collection of peer-reviewed research articles. Majorly, the articles its repository are full of findings that deal with the diagnosis, treatment, and prevention of cancer.
In the light of gaining insight about oncology, Oncotarget has incorporated interdisciplinary latitude for other research papers to be published. Immunology, physiology, pathology, endocrinology, molecular biology, pharmacology, and biochemistry are some of the disciplines whose investigative works have been released by Oncotarget.
One of the major reasons why these fields have been accepted in this journal is because of their contribution towards understanding cancer. With this interdisciplinary collection in one depository, it has enhanced data and information sharing. This has prompted to the development of allosteric techniques and methods of facing the overly increasing threat of cancer. Oncotarget is also available on Dove Press.
More recently, Oncotarget published studies in Gerotargeting which explores age and its relation to cancer. Also, the journal has welcomed on publications from Neuroscience and radiology. This is because neuroscience will best advance knowledge on the management of cancer patients while radiology will work to find safer nuclear medicine treatment options.
By day, Oncotarget is widening their mandate through the multidisciplinary availability of the scientific information. Besides, the journal has provided a platform for oncology research to have an impact via insightful reviews.
Since the creation of Oncotarget in 2010, its effect has been felt far and wide. Thomson Reuter’s assessment has seen its Impact factor rise exponentially. The citations made from its published articles show that its reports are scientifically reliable and valid.
To this end, it is evident that key milestones have been established in cancer diagnosis and treatment. The knowledge available has promoted prevention. Oncotarget has filled the gap.
Download output styles at Endnote.com